Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on July 11, 2006. The report discloses a corporate governance event regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement filing.
Material Changes
The Board of Directors elected Vicki L. Sato, Ph.D., as a new director effective July 11, 2006. Consequently, the size of the Board of Directors was increased to ten members. Dr. Sato is scheduled to stand for election by stockholders at the Annual Meeting in May 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The appointment was not made pursuant to any arrangement or understanding between Dr. Sato and other persons.
Key Facts for Investors
- New Director: Vicki L. Sato, Ph.D., elected effective July 11, 2006.
- Board Size: Increased to ten members.
- Next Election: Dr. Sato will stand for re-election at the May 2007 Annual Meeting.
- Financial Data: No financial metrics are disclosed in this specific filing.